117 related articles for article (PubMed ID: 9796706)
1. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression.
Somerville RP; Shoshan Y; Eng C; Barnett G; Miller D; Cowell JK
Oncogene; 1998 Oct; 17(13):1755-7. PubMed ID: 9796706
[TBL] [Abstract][Full Text] [Related]
2. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
3. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme.
Fults D; Pedone CA; Thompson GE; Uchiyama CM; Gumpper KL; Iliev D; Vinson VL; Tavtigian SV; Perry WL
Int J Oncol; 1998 Apr; 12(4):905-10. PubMed ID: 9499454
[TBL] [Abstract][Full Text] [Related]
5. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
Tsao H; Zhang X; Benoit E; Haluska FG
Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
[TBL] [Abstract][Full Text] [Related]
6. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
[TBL] [Abstract][Full Text] [Related]
7. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
Liu W; James CD; Frederick L; Alderete BE; Jenkins RB
Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744
[TBL] [Abstract][Full Text] [Related]
8. PTEN mutations in gliomas and glioneuronal tumors.
Duerr EM; Rollbrocker B; Hayashi Y; Peters N; Meyer-Puttlitz B; Louis DN; Schramm J; Wiestler OD; Parsons R; Eng C; von Deimling A
Oncogene; 1998 Apr; 16(17):2259-64. PubMed ID: 9619835
[TBL] [Abstract][Full Text] [Related]
9. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
[TBL] [Abstract][Full Text] [Related]
11. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Steck PA; Pershouse MA; Jasser SA; Yung WK; Lin H; Ligon AH; Langford LA; Baumgard ML; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng DH; Tavtigian SV
Nat Genet; 1997 Apr; 15(4):356-62. PubMed ID: 9090379
[TBL] [Abstract][Full Text] [Related]
12. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutations of PTEN in glioblastoma multiforme.
Wang SI; Puc J; Li J; Bruce JN; Cairns P; Sidransky D; Parsons R
Cancer Res; 1997 Oct; 57(19):4183-6. PubMed ID: 9331071
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers.
Kohno T; Takahashi M; Manda R; Yokota J
Genes Chromosomes Cancer; 1998 Jun; 22(2):152-6. PubMed ID: 9598803
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
[TBL] [Abstract][Full Text] [Related]
17. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the PTEN gene in human meningiomas.
Peters N; Wellenreuther R; Rollbrocker B; Hayashi Y; Meyer-Puttlitz B; Duerr EM; Lenartz D; Marsh DJ; Schramm J; Wiestler OD; Parsons R; Eng C; von Deimling A
Neuropathol Appl Neurobiol; 1998 Feb; 24(1):3-8. PubMed ID: 9549723
[TBL] [Abstract][Full Text] [Related]
19. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.
Sasaki H; Zlatescu MC; Betensky RA; Ino Y; Cairncross JG; Louis DN
Am J Pathol; 2001 Jul; 159(1):359-67. PubMed ID: 11438483
[TBL] [Abstract][Full Text] [Related]
20. Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas.
Sanson M; Leuraud P; Aguirre-Cruz L; He J; Marie Y; Cartalat-Carel S; Mokhtari K; Duffau H; Delattre JY; Hoang-Xuan K
J Neurosurg; 2002 Dec; 97(6):1397-401. PubMed ID: 12507139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
